Mary-Anne Young
Biography
Mary-Anne has 40 year’s clinical/research experience encompassing nursing, women’s healthcare and genetic counselling with advanced practitioner clinical expertise in genetic counselling. In 1997 she established the Familial Cancer Centre at Peter MacCallum, the largest familial cancer centre in Australia. In 2016 she joined the Garvan Institute of Medical Research where she is the Clinical Head of the Kinghorn Centre for Clinical Genomics (KCCG).
Mary-Anne is also a clinical researcher with her research arising from her interactions and knowledge of patients specifically how to use research results to better inform clinic practice. Her research primarily focuses on how best to notify research participants of germline genetic information and translating polygenic risk information into clinical practice. Other significant research undertaken has focused on psychosocial support for individuals at high risk of cancer.
Mary-Anne was the first Australasian Genetic Counsellor to be appointed as the President of the Human Genetics Society of Australasia, representing human genetics at a national level.
Video
Mary-Anne has 40 year’s clinical/research experience encompassing nursing, women’s healthcare and genetic counselling with advanced practitioner clinical expertise in genetic counselling. In 1997 she established the Familial Cancer Centre at Peter MacCallum, the largest familial cancer centre in Australia. In 2016 she joined the Garvan Institute of Medical Research where she is the Clinical Head of the Kinghorn Centre for Clinical Genomics (KCCG).
Mary-Anne is also a clinical researcher with her research arising from her interactions and knowledge of patients specifically how to use research results to better inform clinic practice. Her research primarily focuses on how best to notify research participants of germline genetic information and translating polygenic risk information into clinical practice. Other significant research undertaken has focused on psychosocial support for individuals at high risk of cancer.
Mary-Anne was the first Australasian Genetic Counsellor to be appointed as the President of the Human Genetics Society of Australasia, representing human genetics at a national level.
Video
Education
Grad Dip Soc Sci (Fam Therapy) Swinburne University
Selected Publications
- Forrest L, Young M-A. Clinically Significant Germline Mutations in Cancer-Causing Genes Identified Through Research Studies Should Be Offered to Research Participants by Genetic Counselors. J Clin Oncol. 2016 Mar 20;34(9):898-901.
- Willis AM, Smith SK, Meiser B, Ballinger ML, Thomas DM, Young MA. Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counseling for hereditary cancer: a systematic review. Clin Genet. 2017 Aug;92(2):121-133.
- Rasmussen, V., Forrest, L.E., Rogasik, M., Girodet, M., Meeus, P., Sunyach, M.P., Blay, J.Y., Bally, O., Brahmi, M., Ballinger, M.L. Niedermayr, E., Thomas, D., Halliday, J., Ray-Coquard, I., Young, M-A., for the International Sarcoma Kindred Study. A comparison of Australian and French families affected by sarcoma: Perceptions of genetics and incidental findings. Per Med. 2018 Jan;15(1):13-24
- Young, M.A., Forrest, L.E., Rasmussen, V., James, P., Mitchell, G., Sawyer, S., Reeve, K., Hallowell, N., Making sense of SNPs: Women's understanding and experiences of receiving a personalized profile of their breast cancer risks. J Genet Couns. 2018 Jun;27(3):702-708
- Willis AM, Smith SK, Meiser B, Ballinger ML, Thomas DM, Tattersall M; International Sarcoma Kindred Study (ISKS); Kathleen Cuningham National Consortium for Research into Familial Breast Cancer (kConFab), Young MA. Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Finding for Cancer Risk. J Genetc Couns. 2018 Feb 17. Doi: 10.1007/s10897-018-0223
- Forrest, L.E, Sawyer, S.D, Hallowell, N. James, P.A, Young M-A. Communicating polygenic risk in a clinical genetics setting: influence on risk communication tools and receipt of risk information on women’s risk perception. Journal of Community Genet 2018 org/10.1007/s12687-018-0378-0
- Campbell I, Rowley SM, Mascarenhas L, Devereux L, Li N, Amarasinghe KC, Zethoven M,Lee A, Lewis A, Morgan JA, Limb S, Young MA, James P, Trainer AH. Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility. Genet Med. 2018 Sep 26. doi: 10.1038/s41436-018-0277-0.
- Tutty E, PetelinL, McKinleyJ, Young M-A, Meiser B, Rasmussen V, Forbes Shepherd R, James P, Forrest Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serious ovarian cancer Eur J Hum Genet.2019 Aug;27(8):1186-1196. doi: 10.1038/s41431-019-0390-9. Epub 2019 Apr 8.
- Yanes T, Meiser B, KaurR, Scheepers-Joynt M, McInerny S, Taylor S, Barlow-Stewart K, Antill Y, Salmon L, Smyth C, M-A Young, James P.A. Uptake of polygenic risk information among women at increased risk of breast cancer. Clin Genet 2019 Dec;(97):492-501
- Willis AM, Smith SK, Meiser B, Ballinger ML, Thomas DM, Young MA. Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review. Clin Genet. 2017 Aug;92(2):121-133. doi: 10.1111/cge.
- Willis AM, Smith SK, Meiser B, Ballinger ML, Thomas DM, Tattersall M; International Sarcoma Kindred Study (ISKS); Kathleen Cuningham National Consortium for Research into Familial Breast Cancer (kConFab), Young MA. Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Finding for Cancer Risk. J Genetc Couns. 2018 Feb 17. Doi: 10.1007/s10897-018-0223
